110 related articles for article (PubMed ID: 1655341)
21. Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor.
Shibasaki M; Asano M; Fukunaga Y; Usui T; Ichihara M; Murakami Y; Nakano K; Fujikura T
Am J Hypertens; 1991 Dec; 4(12 Pt 1):932-8. PubMed ID: 1815649
[TBL] [Abstract][Full Text] [Related]
22. Effects of a specific and long-acting renin inhibitor in the marmoset.
Wood JM; Gulati N; Forgiarini P; Fuhrer W; Hofbauer KG
Hypertension; 1985; 7(5):797-803. PubMed ID: 3928488
[TBL] [Abstract][Full Text] [Related]
23. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat.
Sechi LA; Griffin CA; Giacchetti G; Valentin JP; Llorens-Cortes C; Corvol P; Schambelan M
Hypertension; 1996 Sep; 28(3):403-8. PubMed ID: 8794824
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of three different potent renin inhibitors in primates.
Clozel JP; Fischli W
Hypertension; 1993 Jul; 22(1):9-17. PubMed ID: 8319997
[TBL] [Abstract][Full Text] [Related]
25. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
26. Effect of renal perfusion pressure on renal function, renin release and renin and angiotensinogen gene expression in rats.
Moosavi SM; Johns EJ
J Physiol; 1999 Oct; 520 Pt 1(Pt 1):261-9. PubMed ID: 10517817
[TBL] [Abstract][Full Text] [Related]
27. Decreased perfusion pressure modulates renin and ANG II type 1 receptor gene expression in the rat kidney.
Tufro-McReddie A; Chevalier RL; Everett AD; Gomez RA
Am J Physiol; 1993 Apr; 264(4 Pt 2):R696-702. PubMed ID: 8476112
[TBL] [Abstract][Full Text] [Related]
28. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
Humke U; Levens N; Wood J; Hofbauer K
J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874
[TBL] [Abstract][Full Text] [Related]
29. Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats.
Haefliger JA; Bergonzelli G; Waeber G; Aubert JF; Nussberger J; Gavras H; Nicod P; Waeber B
Hypertension; 1995 Nov; 26(5):733-7. PubMed ID: 7591011
[TBL] [Abstract][Full Text] [Related]
30. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
[TBL] [Abstract][Full Text] [Related]
31. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
32. Increased plasma renin during renin inhibition. Studies with a novel immunoassay.
Hofbauer KG; Wood JM; Gulati N; Heusser C; Ménard J
Hypertension; 1985; 7(3 Pt 2):I61-5. PubMed ID: 2987126
[TBL] [Abstract][Full Text] [Related]
33. KRI-1314: an orally effective inhibitor of human renin.
Etoh Y; Miyazaki M; Saitoh H; Toda N
Jpn J Pharmacol; 1993 Sep; 63(1):109-19. PubMed ID: 8271523
[TBL] [Abstract][Full Text] [Related]
34. Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
Guzmán-Hernández EA; Villalobos-Molina R; Sánchez-Mendoza MA; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M
Can J Physiol Pharmacol; 2015 Apr; 93(4):299-308. PubMed ID: 25761067
[TBL] [Abstract][Full Text] [Related]
35. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.
von Lutterotti N; Catanzaro DF; Sealey JE; Laragh JH
Circulation; 1994 Jan; 89(1):458-70. PubMed ID: 8281681
[TBL] [Abstract][Full Text] [Related]
36. Kidney renin gene expression in spontaneously hypertensive rats.
Kitami Y; Hiwada K; Kokubu T
J Hypertens; 1989 Sep; 7(9):727-31. PubMed ID: 2677137
[TBL] [Abstract][Full Text] [Related]
37. Acute and chronic effects of renin inhibitor GR70982 in the conscious marmoset.
Gardner CJ; Twissell DJ; Charlton PA; Cherry PC
Eur J Pharmacol; 1991 Jan; 192(3):329-35. PubMed ID: 1905233
[TBL] [Abstract][Full Text] [Related]
38. Influence of the renal sympathetic nerves on renal renin and angiotensinogen gene expression in spontaneously hypertensive rats during development.
Nakamura A; Johns EJ
J Hypertens; 1995 Mar; 13(3):301-9. PubMed ID: 7622851
[TBL] [Abstract][Full Text] [Related]
39. Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension.
Von Thun AM; el-Dahr SS; Vari RC; Navar LG
Hypertension; 1994 Jan; 23(1 Suppl):I131-6. PubMed ID: 7506697
[TBL] [Abstract][Full Text] [Related]
40. Renal and extra-renal renin gene expression in spontaneously hypertensive rats.
Okura T; Kitami Y; Wakamiya R; Marumoto K; Iwata T; Hiwada K
Blood Press Suppl; 1992; 3():6-11. PubMed ID: 1343292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
